Navigation Links
PerkinElmer Shares Future Trends to Improve Testing Systems
Date:3/30/2017

With increasing breadth and depth of genomics studies across a range of cancers, it is now apparent that there exists significant inter and intra tumoural heterogeneity, with complex genotypes comprising of multiple co-existing genetic and epigenetic alterations.

Current efforts being made in genomic characterization of individual cancers still have several limitations, mainly that a significant proportion of patients invariably develop resistance to current targeted therapies, for which the mechanisms are not fully unraveled, and there remain a paucity of treatment options. More than one genomic alteration may co-exist, and the effect of co-mutations can be unpredictable from a target modulation perspective.

In this webinar, sponsored by PerkinElmer, participants will learn from recent studies expanding therapeutic opportunities beyond genomic-based markers. Attendees will learn of the benefits that stem from high content screening in disease biology, as well as the importance of 3D cell culture models and the role they play in cancer heterogeneity and drug resistance.

The speaker for this event will be Dr. Giridharan Periyasamy, platform leader at the Centre for High Throughput Phenomics with the Genome Institute of Singapore.

Periyasamy studied at the Centre for Biotechnology at Anna University, where he earned a doctorate degree in biotechnology. In his current role, he is a platform leader of Centre for High Throughput Phenomics at the Genome institute of Singapore, where his research focuses on the cancer biology, drug resistance, disease modeling and signaling pathway networks of human diseases.

LabRoots will host the webinar April 20th, 2017, beginning at 10:00 a.m. SGT. To read more about this event, learn about the continuing education credits offered, or to register for free, click here.

ABOUT PERKINELMER
PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.1 billion in 2016, has about 9,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at http://www.perkinelmer.com.

ABOUT LABROOTS
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at http://www.prweb.com/releases/2017/03/prweb14189403.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer
2. Global High Throughput Screening (HTS) Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Danaher, PerkinElmer, Sigma-Aldrich and Thermo Fisher
3. Neural ID Enables Auditing and Analysis of Biosignal Data Directly from the TIBCO Spotfire® Powerful Data Visualization Platform for PerkinElmer’s Life Sciences Customers
4. Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific
5. Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference
6. Marken Shares Recent Client Survey Results
7. Bayer Shares the Risk with Cotton Growers
8. Intrexon Announces a Special Stock Dividend of Shares of AquaBounty Technologies
9. Asymmetrex Director Shares Vision for Company and Private Stem Cell Treatment Clinics in Two Arena International Event Group Forums
10. AltaVoice Shares Data on Diseases from its Patient Insights Network
11. Imprimis Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters Option to Purchase Additional Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... , ... They call it the “hairy ball.” It’s an ... a system of linkages and connections so complex and dense that “it looks ... at Worcester Polytechnic Institute (WPI) and director of the university’s bioinformatics and computational ...
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded coverage ... its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats ... sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the ...
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
Breaking Biology Technology:
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
Breaking Biology News(10 mins):